Johnson & Johnson (NYSE: JNJ) today announced sales of $18.5 billion for the third quarter of 2014, an increase of 5.1% as compared to the third quarter of 2013.
The Financial Times has a new report on “Combating Neglected Tropical Diseases (NTDs),” part of a Janssen EMEA-sponsored series on healthcare systems around the world. NTDs are serious health threats for populations in developing countries. Johnson & Johnson is committed to helping those in need through our global public health platform.
The N.J. Chamber of Commerce has named Robert Wood Johnson among its list of All-time Greatest Innovators in recognition of the 350th anniversary of the Garden State. Johnson, who served as CEO and Chairman from 1932 to 1963, is credited with transforming J&J into a global health care company and creating a legacy of innovation.
Welcome to the Johnson & Johnson corporate website home page. The stories on this page are inspired by our commitment to caring for the health and well-being of people around the world.